clinical trial · NCT06605703
A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial)
WW International Inc·phase4·completed·n = 226
ObesityOverweightWW ClinicBupropion-NaltrexoneBupropion-Naltrexone-Metformin
brief summary
The study compares the effectiveness of treatment options for weight management after discontinuing semaglutide and tirzepatide. The primary outcome is absolute and percentage weight change at 12-weeks.
started
Sep 18, 2024
primary completion
Feb 5, 2026
completion
Feb 5, 2026
last updated
Apr 13, 2026
official title
The Comparative Effectiveness of Step-down Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide: A Randomized Controlled Trial (GLP1 Transition Trial)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol